trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Breast Neoplasms D001943 24 associated lipids
Neoplasms D009369 13 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Carcinoma D002277 18 associated lipids
Ureteral Obstruction D014517 10 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Hypersensitivity D006967 22 associated lipids
Osteosarcoma D012516 50 associated lipids
Brain Neoplasms D001932 15 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Melanoma D008545 69 associated lipids
Muscular Dystrophies D009136 10 associated lipids
Asthma D001249 52 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Intellectual Disability D008607 13 associated lipids
Glioma D005910 112 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Endometriosis D004715 29 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Adrenoleukodystrophy D000326 29 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Alzheimer Disease D000544 76 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Leukemia D007938 74 associated lipids
Neuroblastoma D009447 66 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Myeloproliferative Disorders D009196 5 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Fibrosis D005355 23 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Carcinoma, Renal Cell D002292 12 associated lipids
Immunologic Deficiency Syndromes D007153 8 associated lipids
Leukemia, Promyelocytic, Acute D015473 3 associated lipids
Stroke D020521 32 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Nerve Degeneration D009410 53 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Hypertension D006973 115 associated lipids
Tongue Neoplasms D014062 15 associated lipids
Cytomegalovirus Infections D003586 7 associated lipids
Nasal Polyps D009298 26 associated lipids
Leukemia, Myeloid, Acute D015470 19 associated lipids
Mast-Cell Sarcoma D012515 9 associated lipids
Leukemia, Lymphocytic, Chronic, B-Cell D015451 25 associated lipids
Neoplasms, Hormone-Dependent D009376 23 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Translocation, Genetic D014178 20 associated lipids
Cardiomegaly D006332 31 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Radiation Injuries D011832 14 associated lipids
Leishmaniasis D007896 19 associated lipids
Enteritis D004751 8 associated lipids
Primary Myelofibrosis D055728 6 associated lipids
Fetal Growth Retardation D005317 9 associated lipids
Chondrosarcoma D002813 9 associated lipids
Osteomalacia D010018 5 associated lipids
Glioblastoma D005909 27 associated lipids
Keloid D007627 12 associated lipids
Dermatitis, Allergic Contact D017449 20 associated lipids
Medulloblastoma D008527 22 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Lymphatic Metastasis D008207 10 associated lipids
Atherosclerosis D050197 85 associated lipids
Leukemia-Lymphoma, Adult T-Cell D015459 25 associated lipids
Bone Marrow Neoplasms D019046 2 associated lipids
Carcinoma, Pancreatic Ductal D021441 6 associated lipids
Cat Diseases D002371 12 associated lipids
Biliary Tract Neoplasms D001661 7 associated lipids
Neurodegenerative Diseases D019636 32 associated lipids
Polycystic Kidney, Autosomal Dominant D016891 6 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Endometrial Neoplasms D016889 30 associated lipids
Retinoblastoma D012175 12 associated lipids
Genomic Instability D042822 7 associated lipids
Cicatrix, Hypertrophic D017439 4 associated lipids
Carcinoma, Embryonal D018236 8 associated lipids
Mastocytoma D034801 3 associated lipids
Cell Transformation, Viral D002472 26 associated lipids
Nasopharyngeal Neoplasms D009303 4 associated lipids
Fragile X Syndrome D005600 5 associated lipids
Adenocarcinoma, Follicular D018263 3 associated lipids
Hypereosinophilic Syndrome D017681 3 associated lipids
Retinal Neoplasms D019572 3 associated lipids
Progeria D011371 3 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Mazzio EA and Soliman KFA Whole-transcriptomic Profile of SK-MEL-3 Melanoma Cells Treated with the Histone Deacetylase Inhibitor: Trichostatin A. Cancer Genomics Proteomics pmid:30194076
Rahimian A et al. [Inhibition of Histone Deacetylases Reverses Epithelial-Mesenchymal Transition in Triple-Negative Breast Cancer Cells through a Slug Mediated Mechanism]. Mol. Biol. (Mosk.) pmid:29989579
pmid:
Shin S et al. Trichostatin A Sensitizes Hepatocellular Carcinoma Cells to Enhanced NK Cell-mediated Killing by Regulating Immune-related Genes. Cancer Genomics Proteomics pmid:28871002
Yoshida M et al. Effects of trichostatins on differentiation of murine erythroleukemia cells. 1987 Cancer Res. pmid:2439196
Corelli F et al. [Antibacterial and antifungal compounds. VIII. Synthesis and antifungal activity of pyrrol derivatives similar to trichostatin A]. 1987 Farmaco Sci pmid:3329612
Yoshida M and Beppu T Reversible arrest of proliferation of rat 3Y1 fibroblasts in both the G1 and G2 phases by trichostatin A. 1988 Exp. Cell Res. pmid:3134246
Otoguro K et al. Screening for new antitrichomonal substances of microbial origin and antitrichomonal activity of trichostatin A. 1988 J. Antibiot. pmid:3372352
Yoshida M and Beppu T [Trichostatins and leptomycins, new cell cycle inhibitors specific for G1 and G2 phases]. 1989 Tanpakushitsu Kakusan Koso pmid:2678278
Yoshida M et al. Structural specificity for biological activity of trichostatin A, a specific inhibitor of mammalian cell cycle with potent differentiation-inducing activity in Friend leukemia cells. 1990 J. Antibiot. pmid:2211374
Yoshida M et al. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. 1990 J. Biol. Chem. pmid:2211619
Massa S et al. Synthesis and antimicrobial and cytotoxic activities of pyrrole-containing analogues of trichostatin A. 1990 J. Med. Chem. pmid:2213836
[Isolation of drug-resistant mutant cells]. 1991 Tanpakushitsu Kakusan Koso pmid:1745788
Sugita K et al. Morphological reversion of sis-transformed NIH3T3 cells by trichostatin A. 1992 Cancer Res. pmid:1727377
Sugita K et al. A novel compound, depudecin, induces production of transformation to the flat phenotype of NIH3T3 cells transformed by ras-oncogene. 1992 Biochem. Biophys. Res. Commun. pmid:1731795
Kijima M et al. Trapoxin, an antitumor cyclic tetrapeptide, is an irreversible inhibitor of mammalian histone deacetylase. 1993 J. Biol. Chem. pmid:8226751
Almouzni G et al. Histone acetylation influences both gene expression and development of Xenopus laevis. 1994 Dev. Biol. pmid:7958429
Miyashita T et al. Activation of the mouse cytokeratin A (endo A) gene in teratocarcinoma F9 cells by the histone deacetylase inhibitor Trichostatin A. 1994 FEBS Lett. pmid:7523197
Kimura M et al. Dual modes of action of platelet-derived growth factor and its inhibition by trichostatin-A for DNA synthesis in primary cultured smooth muscle cells of rat aorta. 1994 Biol. Pharm. Bull. pmid:8019505
Sanchez del Pino MM et al. Properties of the yeast nuclear histone deacetylase. 1994 Biochem. J. pmid:7980438
Hoshikawa Y et al. Trichostatin A induces morphological changes and gelsolin expression by inhibiting histone deacetylase in human carcinoma cell lines. 1994 Exp. Cell Res. pmid:8082721
Girardot V et al. Relationship between core histone acetylation and histone H1(0) gene activity. 1994 Eur. J. Biochem. pmid:7925412
Thompson EM et al. Real time imaging of transcriptional activity in live mouse preimplantation embryos using a secreted luciferase. 1995 Proc. Natl. Acad. Sci. U.S.A. pmid:7877974
Futamura M et al. Trichostatin A inhibits both ras-induced neurite outgrowth of PC12 cells and morphological transformation of NIH3T3 cells. 1995 Oncogene pmid:7700637
Okabe M et al. Competence effect of PDGF on Ki-67 antigen and DNA contents, and its inhibition by trichostatin-A and a butylydene phthalide BP-421 in primary smooth muscle cells of rat aorta by flow cytometry. 1995 Biol. Pharm. Bull. pmid:8787785
Worrad DM et al. Temporally restricted spatial localization of acetylated isoforms of histone H4 and RNA polymerase II in the 2-cell mouse embryo. 1995 Development pmid:7555721
Yoshida M et al. Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function. 1995 Bioessays pmid:7786288
O'Neill LP and Turner BM Histone H4 acetylation distinguishes coding regions of the human genome from heterochromatin in a differentiation-dependent but transcription-independent manner. 1995 EMBO J. pmid:7664735
Arts J et al. Stimulation of tissue-type plasminogen activator gene expression by sodium butyrate and trichostatin A in human endothelial cells involves histone acetylation. 1995 Biochem. J. pmid:7646441
Lee E et al. Involvement of histone hyperacetylation in triggering DNA fragmentation of rat thymocytes undergoing apoptosis. 1996 FEBS Lett. pmid:8898091
Taunton J et al. A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p. 1996 Science pmid:8602529
Van Lint C et al. Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. 1996 EMBO J. pmid:8605881
Carmen AA et al. HDA1 and HDA3 are components of a yeast histone deacetylase (HDA) complex. 1996 J. Biol. Chem. pmid:8663039
Van Lint C et al. The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. 1996 Gene Expr. pmid:8723390
Takahashi I et al. Selective inhibition of IL-2 gene expression by trichostatin A, a potent inhibitor of mammalian histone deacetylase. 1996 J. Antibiot. pmid:8682722
Zhang J et al. Basis for the loss of aryl hydrocarbon receptor gene expression in clones of a mouse hepatoma cell line. 1996 Mol. Pharmacol. pmid:8967965
Yoshida M [Molecular targets of cell cycle inhibitors and their mode of action]. 1996 Tanpakushitsu Kakusan Koso pmid:8890633
Sano M and Kitajima S Inhibition of the nerve growth factor-induced outgrowth of neurites by trichostatin A requires protein synthesis de novo in PC12D cells. 1996 Brain Res. pmid:9117395
Bartsch J et al. Moderate increase in histone acetylation activates the mouse mammary tumor virus promoter and remodels its nucleosome structure. 1996 Proc. Natl. Acad. Sci. U.S.A. pmid:8855250
Ogryzko VV et al. Human fibroblast commitment to a senescence-like state in response to histone deacetylase inhibitors is cell cycle dependent. 1996 Mol. Cell. Biol. pmid:8756678
Yamamoto I et al. Histone hyperacetylation plays a role in augmentation of IL-4-induced IgE production in LPS-stimulated murine B-lymphocytes by sodium butyrate. 1996 J. Biochem. pmid:8827437
McBain JA et al. Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacetylase inhibitors. 1997 Biochem. Pharmacol. pmid:9214697
Ohno Y et al. Macrophage inflammatory protein-2: chromosomal regulation in rat small intestinal epithelial cells. 1997 Proc. Natl. Acad. Sci. U.S.A. pmid:9294201
Huang N et al. Inhibition of IL-8 gene expression in Caco-2 cells by compounds which induce histone hyperacetylation. 1997 Cytokine pmid:9067093
Garcia-Villalba P et al. Histone acetylation influences thyroid hormone and retinoic acid-mediated gene expression. 1997 DNA Cell Biol. pmid:9150429
Chen WY et al. Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase. 1997 Proc. Natl. Acad. Sci. U.S.A. pmid:9159154
Sowa Y et al. Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites. 1997 Biochem. Biophys. Res. Commun. pmid:9405248
Sheridan PL et al. Histone acetyltransferases regulate HIV-1 enhancer activity in vitro. 1997 Genes Dev. pmid:9407026
Minucci S et al. A histone deacetylase inhibitor potentiates retinoid receptor action in embryonal carcinoma cells. 1997 Proc. Natl. Acad. Sci. U.S.A. pmid:9326603
Ekwall K et al. Transient inhibition of histone deacetylation alters the structural and functional imprint at fission yeast centromeres. 1997 Cell pmid:9428524
Xu L et al. Effect of the histone deacetylase inhibitor trichostatin A on the responsiveness of rat hepatocytes to dioxin. 1997 Biochem. Pharmacol. pmid:9174108
Stein P et al. Stage-dependent redistributions of acetylated histones in nuclei of the early preimplantation mouse embryo. 1997 Mol. Reprod. Dev. pmid:9211426
Sommer A et al. Cell growth inhibition by the Mad/Max complex through recruitment of histone deacetylase activity. 1997 Curr. Biol. pmid:9197243
Jenster G et al. Steroid receptor induction of gene transcription: a two-step model. 1997 Proc. Natl. Acad. Sci. U.S.A. pmid:9223281
Nagy L et al. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. 1997 Cell pmid:9150137
Goldman MA Executive decision: chromatin structure and gene regulation. 1997 Trends Genet. pmid:9351338
Dion LD et al. Amplification of recombinant adenoviral transgene products occurs by inhibition of histone deacetylase. 1997 Virology pmid:9168882
Chen ZJ and Pikaard CS Epigenetic silencing of RNA polymerase I transcription: a role for DNA methylation and histone modification in nucleolar dominance. 1997 Genes Dev. pmid:9284051
Medina V et al. Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): dependence on protein synthesis and synergy with a mitochondrial/cytochrome c-dependent pathway. 1997 Cancer Res. pmid:9288776
Koguchi Y et al. Trichostatin A and herboxidiene up-regulate the gene expression of low density lipoprotein receptor. 1997 J. Antibiot. pmid:9592573
Dangond F and Gullans SR Differential expression of human histone deacetylase mRNAs in response to immune cell apoptosis induction by trichostatin A and butyrate. 1998 Biochem. Biophys. Res. Commun. pmid:9647779
Lin RJ et al. Role of the histone deacetylase complex in acute promyelocytic leukaemia. 1998 Nature pmid:9486654
Grignani F et al. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. 1998 Nature pmid:9486655
Wong J et al. Distinct requirements for chromatin assembly in transcriptional repression by thyroid hormone receptor and histone deacetylase. 1998 EMBO J. pmid:9430643
Komatsu Y and Hayashi H Histone deacetylase inhibitors up-regulate the expression of cell surface MHC class-I molecules in B16/BL6 cells. 1998 J. Antibiot. pmid:9531994
Magnaghi-Jaulin L et al. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. 1998 Nature pmid:9468140
Svensson K et al. The paternal allele of the H19 gene is progressively silenced during early mouse development: the acetylation status of histones may be involved in the generation of variegated expression patterns. 1998 Development pmid:9389664
Emiliani S et al. Characterization of a human RPD3 ortholog, HDAC3. 1998 Proc. Natl. Acad. Sci. U.S.A. pmid:9501169
El Kharroubi A et al. Transcriptional activation of the integrated chromatin-associated human immunodeficiency virus type 1 promoter. 1998 Mol. Cell. Biol. pmid:9566873
Gray SG and Ekström TJ Effects of cell density and trichostatin A on the expression of HDAC1 and p57Kip2 in Hep 3B cells. 1998 Biochem. Biophys. Res. Commun. pmid:9571167
Belyaev ND et al. The acetylation patterns of histones H3 and H4 along Vicia faba chromosomes are different. 1998 Chromosome Res. pmid:9510512
Nan X et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. 1998 Nature pmid:9620804
Kim YB et al. phd1+, a histone deacetylase gene of Schizosaccharomyces pombe, is required for the meiotic cell cycle and resistance to trichostatin A. 1998 FEBS Lett. pmid:9781677
Richon VM et al. A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases. 1998 Proc. Natl. Acad. Sci. U.S.A. pmid:9501205
Egawa K et al. Identification of active substances from Streptomyces culture fluids using p53-independent expression of p21/WAF1/Cip1 gene and their mode of action. 1998 Biol. Pharm. Bull. pmid:9781835
Kohge T et al. Promotion of antigen-specific antibody production in murine B cells by a moderate increase in histone acetylation. 1998 Biochem. Pharmacol. pmid:9825735
Grewal SI et al. Histone deacetylase homologs regulate epigenetic inheritance of transcriptional silencing and chromosome segregation in fission yeast. 1998 Genetics pmid:9755190
Preston CM and McFarlane M Cytodifferentiating agents affect the replication of herpes simplex virus type 1 in the absence of functional VP16. 1998 Virology pmid:9791032
Hu JF et al. The role of histone acetylation in the allelic expression of the imprinted human insulin-like growth factor II gene. 1998 Biochem. Biophys. Res. Commun. pmid:9792787
Llorente A et al. Expression of mutant dynamin inhibits toxicity and transport of endocytosed ricin to the Golgi apparatus. 1998 J. Cell Biol. pmid:9456316
Korhonen P et al. Expression of transcriptional repressor protein mSin3A but not mSin3B is induced during neuronal apoptosis. 1998 Biochem. Biophys. Res. Commun. pmid:9813182
Waterborg JH Dynamics of histone acetylation in Chlamydomonas reinhardtii. 1998 J. Biol. Chem. pmid:9765294
Madisen L et al. The immunoglobulin heavy chain locus control region increases histone acetylation along linked c-myc genes. 1998 Mol. Cell. Biol. pmid:9774645
Eden S et al. DNA methylation models histone acetylation. 1998 Nature pmid:9732866
Phelan MW et al. Hypoxia increases thrombospondin-1 transcript and protein in cultured endothelial cells. 1998 J. Lab. Clin. Med. pmid:9851743
Ciana P et al. Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo. 1998 EMBO J. pmid:9857194
De Luca P et al. Retinoblastoma protein tethered to promoter DNA represses TBP-mediated transcription. 1998 J. Cell. Biochem. pmid:9671233
Selker EU Trichostatin A causes selective loss of DNA methylation in Neurospora. 1998 Proc. Natl. Acad. Sci. U.S.A. pmid:9689097
Jin S and Scotto KW Transcriptional regulation of the MDR1 gene by histone acetyltransferase and deacetylase is mediated by NF-Y. 1998 Mol. Cell. Biol. pmid:9632821
Nakajima H et al. FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor. 1998 Exp. Cell Res. pmid:9633520
Thompson EM and Renard JP Preferential nuclear location of a transgene does not depend on its transcriptional activity during early mouse development. 1998 Chromosoma pmid:9880765
Durum SK et al. Interleukin 7 receptor control of T cell receptor gamma gene rearrangement: role of receptor-associated chains and locus accessibility. 1998 J. Exp. Med. pmid:9858510
Nemer M Histone deacetylase mRNA temporally and spatially regulated in its expression in sea urchin embryos. 1998 Dev. Growth Differ. pmid:9865968
Ishiguro K and Sartorelli AC Coinduction of embryonic and adult-type globin mRNAs by sodium butyrate and trichostatin A in two murine interleukin-3-dependent bone marrow-derived cell lines. 1998 Blood pmid:9834245
Walia H et al. Histone acetylation is required to maintain the unfolded nucleosome structure associated with transcribing DNA. 1998 J. Biol. Chem. pmid:9603965
Bakin AV and Curran T Role of DNA 5-methylcytosine transferase in cell transformation by fos. 1999 Science pmid:9888853
Carmen AA et al. Yeast HOS3 forms a novel trichostatin A-insensitive homodimer with intrinsic histone deacetylase activity. 1999 Proc. Natl. Acad. Sci. U.S.A. pmid:10535926
Rüller S et al. Sensitization of tumor cells to ribotoxic stress-induced apoptotic cell death: a new therapeutic strategy. 1999 Clin. Cancer Res. pmid:10537334
Vanden Berghe W et al. The nuclear factor-kappaB engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter. 1999 J. Biol. Chem. pmid:10542243
Ng HH et al. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. 1999 Nat. Genet. pmid:10471499